← Leaderboards
Triparna Sen
Sloan-Kettering Inst Can Research
$3,760,270
Attributed
$3,760,270
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,760,270 · 3
By mechanism
R01$3,760,270 · 3
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Tuomas Tammela$7,490,282
- Scott W Lowe$63,222,126
- Timothy An-Thy Chan$21,076,830
- Craig B Thompson$56,520,903
- John Thomas Poirier$4,490,380
Others in their field
Other Emerging Leaders on “Malignant Neoplasm Of Lung”
- Leonard Freedman · Leidos Biomedical Research, Inc.$50,919,602
- Greg Yothers · University Of Chicago$35,003,821
- Lynn Briscoe · Leidos Biomedical Research, Inc.$26,085,158
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,658,268
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- John Freymann · Leidos Biomedical Research, Inc.$14,011,208
Research focus
Malignant Neoplasm Of LungCellsPreventTumorMolecularGeneticOverexpressionPre-Clinical ModelSignal TransductionNovel Therapeutic InterventionNovel TherapeuticsResistanceMultidisciplinaryPathway InteractionsChemotherapyCancer ModelCancer PatientCessation Of LifeAntitumor ResponseCancer SubtypesMediatingMissionAffectBiology
Grant awards (8)
Defining and overcoming lineage plasticity in lung cancer$631,156
R01 · FY2025 · CA · contact PI
Targeting replication stress signaling to overcome immune evasion in small cell lung cancer$490,061
R01 · FY2025 · CA · contact PI
Targeting ferroptosis in aggressive subtypes of lung cancer$462,704
R01 · FY2025 · CA · contact PI
Targeting ferroptosis in aggressive subtypes of lung cancer$227,210
R01 · FY2025 · CA · contact PI
Targeting replication stress signaling to overcome immune evasion in small cell lung cancer$465,558
R01 · FY2024 · CA · contact PI
Targeting replication stress signaling to overcome immune evasion in small cell lung cancer$480,259
R01 · FY2023 · CA · contact PI
Targeting replication stress signaling to overcome immune evasion in small cell lung cancer$490,061
R01 · FY2022 · CA · contact PI
Targeting replication stress signaling to overcome immune evasion in small cell lung cancer$513,261
R01 · FY2021 · CA · contact PI